You're reading the free version. Trader adds the live tape and alerts.
Start tracking
LGND Sale Disclosure
Reardon Andrew · SEC Form 4 · Filed Sep 8, 2026
Sale
Calculated transaction value
$110.7K
Reardon Andrew CLO & Secretary
LGND
Transaction date
Sep 3, 2026
Public filing date
Sep 8, 2026
Filing lag
Filed 5 days later
LGND daily price context
Close on/before transaction
$289.74
Sep 3, 2026
First close after public filing
$288.05
Sep 9, 2026
30-day return after filing
+2.41%
Through Oct 8, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 385 shares @ $287.53
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0002001011-26-000137
Filing cohort
Transactions in this filing
Showing 5 of 5
Trades
5
Issuers
1
Estimated value
$1.43M
Buys / sales
0 / 5
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Ligand Pharmaceuticals Inc LGND Current | Sale | Sep 3, 2026 | $110.7K |
| Ligand Pharmaceuticals Inc LGND | Sale | Sep 3, 2026 | $85.2K |
| Ligand Pharmaceuticals Inc LGND | Sale | Sep 3, 2026 | $115.59K |
| Ligand Pharmaceuticals Inc LGND | Sale | Sep 3, 2026 | $513.3K |
| Ligand Pharmaceuticals Inc LGND | Sale | Sep 3, 2026 | $605.65K |